Hims & Hers Health Inc (HIMS)

Apr 23, 2025, 11:21 AM EDT - 11 hours ago

Hims & Hers: Look Past Near-Term GLP-1 Risks, This Is A Great Dip To Buy

Apr 21, 2025, 12:35 PM EDT - 2 days ago

Hims & Hers: Top Pick For The Next Decade

Apr 2, 2025, 2:12 PM EDT - 21 days ago

Hims & Hers Zepbound Offering Won't Bring Needed Sales Boom, Analysts Say

Apr 1, 2025, 7:44 PM EDT - 22 days ago

Hims & Hers shares rise as company adds Eli Lilly's Zepbound

LLY

Apr 1, 2025, 7:38 PM EDT - 22 days ago

Hims & Hers Expands Weight Loss Offering, Adds Lilly's Zepbound to Platform

LLY

Apr 1, 2025, 3:21 PM EDT - 22 days ago

Hims & Hers shares rise as company adds new weight-loss medications to platform

Apr 1, 2025, 1:39 PM EDT - 22 days ago

Hims & Hers to sell Lilly's Zepbound on its telehealth platform

LLY

Mar 27, 2025, 4:13 AM EDT - 27 days ago

Here's why Hims & Hers stock price has crashed: buy the dip?

Mar 26, 2025, 9:15 AM EDT - 4 weeks ago

Hims & Hers Health: Reaching Escape Velocity Goes Unnoticed By The Market

Mar 25, 2025, 6:11 AM EDT - 4 weeks ago

The Case For Hims & Hers: Diversification And Growth Beyond Semaglutide

Mar 20, 2025, 4:38 PM EDT - 4 weeks ago

Hims & Hers Health: Developing A Better Understanding

Mar 20, 2025, 1:40 PM EDT - 4 weeks ago

Jumping Into The FDA Gamble: Initiating Hims & Hers With A Buy

Mar 20, 2025, 11:35 AM EDT - 4 weeks ago

Hims & Hers Has Superstar Potential, But It Will Take A Lot To Get There

Mar 13, 2025, 1:00 AM EDT - 5 weeks ago

Defiance Launches RKLX and HIMZ: 2X Leveraged ETFs for Rocket Lab and Hims & Hers

RKLB

Mar 9, 2025, 12:38 AM EST - 6 weeks ago

Hims & Hers: AI-Powered Healthcare Disruption

Mar 7, 2025, 6:21 PM EST - 6 weeks ago

Hims & Hers to shut down dermatology business Apostrophe

Mar 7, 2025, 6:19 PM EST - 6 weeks ago

DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

ALK AMBC ATI BBWI BWA CC CE

Mar 7, 2025, 3:24 PM EST - 6 weeks ago

Hims and Hers just shut down its dermatology business after stock slump on FDA's weight-loss drug decision

Mar 7, 2025, 9:05 AM EST - 6 weeks ago

Hims & Hers: The Odds Are In Your Favor, Here's How To Take Advantage (Rating Upgrade)

Mar 5, 2025, 10:56 AM EST - 7 weeks ago

Novo Nordisk's Cheaper Wegovy Offering Is Bad News for Hims & Hers

NVO

Mar 5, 2025, 10:37 AM EST - 7 weeks ago

Why Is Hims & Hers Health Stock Trading Lower On Wednesday?

Mar 3, 2025, 11:47 AM EST - 7 weeks ago

Hims & Hers' Fall From Grace Is Warranted - Still No Margin Of Safety

Mar 2, 2025, 9:30 AM EST - 7 weeks ago

Hims & Hers: A Generational Dip-Buying Opportunity

Feb 27, 2025, 6:39 AM EST - 7 weeks ago

Hims & Hers: Shortage-Driven Sell-Off Appears Overdone; Buy

Feb 26, 2025, 10:02 AM EST - 2 months ago

Hims & Hers: Down 45% In 5 Days, Is The Stock Still A Buy?

Feb 25, 2025, 2:22 PM EST - 2 months ago

Hims & Hers Health: Focus On The Future, Not GLP-1s

Feb 25, 2025, 10:56 AM EST - 2 months ago

Hims & Hers shares plunge 28% on concerns over weight loss business, margins

Feb 25, 2025, 10:52 AM EST - 2 months ago

Hims & Hers CFO talks Q4 earnings

Feb 25, 2025, 10:30 AM EST - 2 months ago

HIMS Trims, ZM's Guidance Glitch & PYPL Reaffirms Guidance

PYPL ZM

Feb 25, 2025, 8:54 AM EST - 2 months ago

Bitcoin Concerns, SPX Upside to "$6030" & HIMS Sinks

ARKB ARKW BETE BETH BITB BITC BITO

Feb 25, 2025, 7:29 AM EST - 2 months ago

Novo Nordisk's stock is rallying as Hims & Hers' stock falters. An Ozempic alternative won't be available for long.

NVO

Feb 25, 2025, 7:21 AM EST - 2 months ago

Hims & Hers shares drop on doubts over weight-loss business forecast

Feb 25, 2025, 6:47 AM EST - 2 months ago

Hims & Hers: Capitalizing On The GLP-1 Rush Before The Window Closes (Rating Upgrade)

Feb 25, 2025, 4:20 AM EST - 2 months ago

Hims & Hers Earnings: Very Strong Business, In A Very Crowded Trade

Feb 25, 2025, 4:01 AM EST - 2 months ago

Hims & Hers: Why This Q4 Earnings Dip Is A Buying Opportunity

Feb 24, 2025, 9:54 PM EST - 2 months ago

Hims & Hers: Post Earnings Drop Is Very Welcomed

Feb 24, 2025, 7:42 PM EST - 2 months ago

Hims & Hers Health, Inc. (HIMS) Q4 2024 Earnings Call Transcript

Feb 24, 2025, 6:05 PM EST - 2 months ago

Hims & Hers Shares Plunge as Costs Tied to Weight-Loss Drugs Squeeze Margins

Feb 24, 2025, 5:56 PM EST - 2 months ago

Hims & Hers shares tumble over concerns around weight-loss business

Feb 24, 2025, 5:26 PM EST - 2 months ago

Hims & Hers warns its supply of compounded weight loss drugs could be 'constrained'

Feb 24, 2025, 4:59 PM EST - 2 months ago

Hims & Hers offers upbeat forecast, but stock slides after hours

Feb 24, 2025, 4:43 PM EST - 2 months ago

Hims & Hers shares tumble 18% as margin miss adds to concerns about GLP-1 business

Feb 24, 2025, 4:05 PM EST - 2 months ago

Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 24, 2025, 9:09 AM EST - 2 months ago

Options Corner: HIMS Earnings Ahead

Feb 24, 2025, 1:45 AM EST - 2 months ago

Hims & Hers Declines - How The GLP-1 Market Shift Affects Growth

Feb 21, 2025, 4:34 PM EST - 2 months ago

Overlooked Stock: HIMS

Feb 21, 2025, 1:19 PM EST - 2 months ago

Hims & Hers Stock Plummets. The Wegovy Shortage Is Over.

Feb 21, 2025, 12:56 PM EST - 2 months ago

Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage

Feb 21, 2025, 11:01 AM EST - 2 months ago

HIMS stock crashes 25% on Friday after this key FDA update

Feb 21, 2025, 9:00 AM EST - 2 months ago

Hims & Hers Acquires US-based Peptide Facility